Pfizer Net Current Debt 2010-2024 | PFE
Pfizer annual/quarterly net current debt history and growth rate from 2010 to 2024. Net current debt can be defined as the net amount of debt repaid and issued with short-term maturities.
- Pfizer net current debt for the quarter ending December 31, 2024 was $-4.909B, a 163.89% decline year-over-year.
- Pfizer net current debt for the twelve months ending December 31, 2024 was $-7.960B, a 201.22% decline year-over-year.
- Pfizer annual net current debt for 2024 was $-4.909B, a 163.89% decline from 2023.
- Pfizer annual net current debt for 2023 was $7.683B, a 3624.31% decline from 2022.
- Pfizer annual net current debt for 2022 was $-0.218B, a 127.08% increase from 2021.
Pfizer Annual Net Current Debt
(Millions of US $) |
| 2024 |
$-4,909 |
| 2023 |
$7,683 |
| 2022 |
$-218 |
| 2021 |
$-96 |
| 2020 |
$-13,974 |
| 2019 |
$10,628 |
| 2018 |
$-2,343 |
| 2017 |
$-61 |
| 2016 |
$-681 |
| 2015 |
$4,309 |
| 2014 |
$-1,838 |
| 2013 |
$3,564 |
| 2012 |
$-212 |
| 2011 |
$1,444 |
| 2010 |
$-4,146 |
| 2009 |
$-2,936 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$125.566B |
$63.627B |
|
Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare Disease, Hospital, Vaccines and Internal Medicine. Pfizer spinned-off its Upjohn unit, its off-patent branded and generic established medicines business, and combined it with generic drugmaker Mylan to create a new generic pharmaceutical company called Viatris. The Consumer Healthcare (CHC) segment, an over-the-counter (OTC) medicines business, was merged with Glaxo's unit to form a new joint venture.?The Consumer Healthcare joint venture with Glaxo and the merger of Upjohn unit with Mylan has made Pfizer a smaller company with a diversified portfolio of innovative drugs and vaccines.
|
